Pancreas-specific Cre driver lines and considerations for their prudent use.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23823474.
- Also identified by DOI 10.1016/j.cmet.2013.06.011 and PMC identifier 3732107.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cre/LoxP has broad utility for studying the function, development, and oncogenic transformation of pancreatic cells in mice. Here we provide an overview of the Cre driver lines that are available for such studies. We discuss how variegated expression, transgene silencing, and recombination in undesired cell types have conspired to limit the performance of these lines, sometimes leading to serious experimental concerns. We also discuss preferred strategies for achieving high-fidelity driver lines and remind investigators of the continuing need for caution when interpreting results obtained from any Cre/LoxP-based experiment performed in mice.
Medical subject headings
- DNA Nucleotidyltransferases
- Integrases
- Pancreas
- Recombination, Genetic